| LIORX | TRTIX | LIORX / TRTIX | |
| Total Expense Ratio | 1.50 | 0.68 | 221% |
| Annual Report Gross Expense Ratio | 1.50 | 0.68 | 221% |
| Fund Existence | 12 years | 11 years | - |
| Gain YTD | 12.472 | 12.962 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 214M | 17B | 1% |
| Annual Yield % from dividends | 3.33 | 2.52 | 132% |
| Returns for 1 year | 26.80 | 28.51 | 94% |
| Returns for 3 years | 60.15 | 83.95 | 72% |
| Returns for 5 years | 62.69 | 94.24 | 67% |
| Returns for 10 years | 107.55 | 158.80 | 68% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DXD | 17.09 | 0.08 | +0.47% |
| ProShares UltraShort Dow30 | |||
| SMMV | 46.50 | 0.13 | +0.27% |
| iShares MSCI USA Sm-Cp Min Vol Fctr ETF | |||
| CCOM | 23.80 | N/A | N/A |
| Simplify Chinese Cmdts Stgy No K-1 ETF | |||
| LFSC | 46.29 | N/A | N/A |
| F/m Emerald Life Sciences Innovation ETF | |||
| HYT | 8.48 | -0.04 | -0.47% |
| Blackrock Corporate High Yield Fund | |||